Sentence examples for markers are appropriate from inspiring English sources

Regular and frequent measurements of these markers are appropriate throughout the clinical management of patients with malignant teratoma.

SNP markers are appropriate for detecting selectively-channeled adaptive genetic diversity in natural populations of wild emmer wheat.

In this study, we aimed to determine whether the plasma levels of NT-proBNP, CCR, and other biomarkers altered with changes in the severity of heart failure and whether these markers are appropriate in immediately identifying symptomatic or asymptomatic heart failure in patients.

Therefore, analysis of CSF biochemical markers is appropriate to describe different pathophysiological changes in this brain region.

Haplotype estimation was conducted in several stages using two software packages (Haploview [ 28] and Phase v2.1 [ 29, 30]): Haploview was first run on the markers for each multi-marker gene to identify the linkage disequilibrium structure and check to ensure that the markers were appropriate for inclusion in the haplotype estimates.

This Request for Application (RFA) will establish Clinical Proteomics Programs to promote systematic, comprehensive, large-scale validation of existing and new candidate protein markers that are appropriate for routine use in the diagnosis and management of heart, lung, blood, and sleep diseases.

Articles including studies that evaluated SAA levels as diagnostic markers for NS are appropriate.

The stable expression of foreign DNA in BCG on a plasmid vector established a basis for the construction of polyvalent recombinant BCG vaccine but the antibiotic resistance markers are not appropriate for the selection or maintenance of recombinant plasmid containing antigens.

The detection of ASF specific antibodies is indicative of previous infection [ 37], and since antibodies are produced from the first week of infection and persist for long periods they are appropriate markers for the diagnosis of the disease [ 33].

Moreover, questions arise: 'When does an outcome actually have impact?', 'What are appropriate quality markers?', 'What changes in policy would constitute impact?' and 'What time frame for impact is realistic?'.

Our extended analysis would thus emphasise that no unique protein marker may be appropriate to classify such a heterogeneous disease, and reinforces the notion that a combination of protein markers is possibly necessary to allow the correct distinction of normal and cancerous ovarian epithelial cells.